SEC Comment Letter 0000000000-24-009240 to Organogenesis Holdings Inc. (ORGO) (CIK 0001661181) (ORGO)
Organogenesis Holdings Inc. (ORGO) (CIK 0001661181)
Date: Aug. 13, 2024 · CIK: 0001661181 · Accession: 0000000000-24-009240
AI Filing Summary & Sentiment
File numbers found in text: 333-281392
Letter
August 13, 2024 Gary S. Gillheeney Chief Executive Officer, President and Chair of the Board of Directors Organogenesis Holdings Inc. 85 Dan Road Canton, Massachusetts 02021 Re:Organogenesis Holdings Inc. Registration Statement on Form S-3 Filed August 8, 2024 File No. 333-281392 Dear Gary S. Gillheeney: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Ryan M. Rourke Reed
Show Raw Text
August 13, 2024
Gary S. Gillheeney
Chief Executive Officer, President and Chair of the Board of Directors
Organogenesis Holdings Inc.
85 Dan Road
Canton, Massachusetts 02021
Re:Organogenesis Holdings Inc.
Registration Statement on Form S-3
Filed August 8, 2024
File No. 333-281392
Dear Gary S. Gillheeney:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Ryan M. Rourke Reed